Correlation Between Fate Therapeutics and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Akero Therapeutics, you can compare the effects of market volatilities on Fate Therapeutics and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Akero Therapeutics.
Diversification Opportunities for Fate Therapeutics and Akero Therapeutics
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Fate and Akero is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Akero Therapeutics
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Akero Therapeutics. In addition to that, Fate Therapeutics is 2.03 times more volatile than Akero Therapeutics. It trades about -0.14 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest 2,934 in Akero Therapeutics on September 26, 2024 and sell it today you would lose (78.00) from holding Akero Therapeutics or give up 2.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. Akero Therapeutics
Performance |
Timeline |
Fate Therapeutics |
Akero Therapeutics |
Fate Therapeutics and Akero Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Akero Therapeutics
The main advantage of trading using opposite Fate Therapeutics and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Akero Therapeutics vs. Fate Therapeutics | Akero Therapeutics vs. Caribou Biosciences | Akero Therapeutics vs. Karyopharm Therapeutics | Akero Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |